Frazier Lifesciences Acquisition Corporation Stock
Stocks
NAMS
NL00150012L7
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.88 EUR | -14.05% |
|
-8.04% | -20.78% |
| Market Cap | 2.79B 3.22B 2.6B 2.39B 4.52B 306B 4.57B 30.7B 12B 153B 12.08B 11.81B 507B | P/E 2026 * |
-15.2x | P/E 2027 * | -18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.39B 2.75B 2.23B 2.05B 3.87B 262B 3.92B 26.28B 10.27B 131B 10.34B 10.11B 434B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 16.9x |
| Free-Float |
99.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Frazier Lifesciences Acquisition Corporation
| 1 day | -14.05% | ||
| 1 week | -8.04% | ||
| 1 month | -20.21% | ||
| 3 months | -2.25% | ||
| 6 months | -15.76% | ||
| Current year | -20.78% |
| 1 week | 26.91 |  | 29.13 |
| 1 month | 26.91 | | 37.37 |
| Current year | 26.91 | | 42.2 |
| 1 year | 21.23 | | 42.2 |
| 3 years | 5.63 | | 42.2 |
| 5 years | 5.63 | | 42.2 |
| 10 years | 5.63 | | 42.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Davidson
CEO | Chief Executive Officer | 69 | 2022-10-31 |
Mayur Somaiya
DFI | Director of Finance/CFO | 52 | 2023-10-22 |
Douglas Kling
COO | Chief Operating Officer | 53 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Davidson
BRD | Director/Board Member | 69 | 2022-10-31 |
John Kastelein
BRD | Director/Board Member | 72 | 2022-10-31 |
James Topper
BRD | Director/Board Member | 64 | 2022-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/20/26 | Fiscal year | Controller/Auditor | 315,000 | 0.2695% | ||
| 3/2/26 | Fiscal year | Chief Executive Officer | 1,331,121 | 1.1577% | ||
| 2/24/26 | Fiscal year | Chief Executive Officer | 918,879 | 0.8104% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.05% | -8.04% | +30.59% | +147.02% | 3.21B | |
| +10.00% | +13.39% | +51.99% | +83.45% | 56.7B | |
| +0.80% | -7.82% | +24.61% | +60.00% | 51.97B | |
| +8.86% | -1.08% | -16.89% | -14.12% | 23.33B | |
| +2.01% | -5.22% | -11.28% | +348.79% | 21.34B | |
| +1.73% | -1.57% | +32.81% | -25.80% | 17.44B | |
| +4.29% | +1.67% | +201.24% | +344.48% | 14.77B | |
| +2.71% | -0.67% | +52.49% | +176.91% | 13.84B | |
| +7.57% | +3.92% | +441.39% | +181.64% | 12.12B | |
| +2.30% | -5.47% | +63.19% | +161.89% | 11.14B | |
| Average | +1.34% | -1.37% | +87.01% | +146.43% | 22.59B | |
| Weighted average by Cap. | +3.44% | +0.32% | +62.05% | +117.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.89M 26.36M 21.34M 19.6M 37.07M 2.51B 37.48M 252M 98.34M 1.25B 98.98M 96.81M 4.15B | 133M 153M 124M 114M 216M 14.6B 218M 1.46B 573M 7.3B 576M 564M 24.18B |
| Net income | -192M -222M -179M -165M -312M -21.08B -315M -2.11B -827M -10.54B -832M -814M -34.91B | -166M -191M -155M -142M -269M -18.19B -272M -1.83B -714M -9.09B -718M -702M -30.13B |
| Net Debt | -402M -463M -375M -344M -651M -44.03B -658M -4.42B -1.73B -22.01B -1.74B -1.7B -72.93B | -538M -620M -502M -461M -872M -58.96B -881M -5.92B -2.31B -29.47B -2.33B -2.28B -97.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | €27.79 | -2.35% | 956,633 |
| 26-08-03 | €27.49 | -1.08% | 1,012,542 |
| 26-07-31 | €27.79 | -2.35% | 956,633 |
| 26-07-30 | €28.46 | +1.97% | 611,371 |
| 26-07-29 | €27.91 | -0.25% | 1,301,217 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAMS Stock
Select your edition
All financial news and data tailored to specific country editions
